Thyrocare Technologies Limited
Thyrocare Technologies Limited is an Indian listed company in the Healthcare Services industry (Healthcare sector), traded under NSE: THYROCARE and BSE: 539871 (ISIN INE594H01019).
It has a market capitalisation of ₹7,497 crore, a last close of ₹471.00 on 2026-10-19, a one-year return of 13.6%.
Valuation: a price-to-earnings ratio of 42.52x, a price-to-book ratio of 12.80x, a dividend yield of 2.0%.
Profitability: return on equity of 28.8%, return on capital employed of 35.5%, an operating margin of 32.1%.
Growth: sales growth of 16.3% a year over three years, net profit growth of 36.2% a year over three years.
Balance sheet and ownership: debt-to-equity of 0.00x, promoter holding of 51.0%.
| Metric | Value |
|---|---|
| Market capitalisation | 7,497 |
| Last close | ₹471.00 |
| P/E (TTM) | 42.52x |
| P/B | 12.80x |
| Dividend yield | 2.0% |
| ROE (FY) | 28.8% |
| ROCE (FY) | 35.5% |
| Operating margin (TTM) | 32.1% |
| Sales growth, 3-year CAGR | 16.3% |
| Profit growth, 3-year CAGR | 36.2% |
| Debt / equity | 0.00x |
| Promoter holding | 51.0% |
| 1-year return | 13.6% |
Loading the live page with the price chart, financial history, shareholding and recent filings. Data is end-of-day and rebuilt nightly; nothing here is investment advice. Financial statements · What each metric means